Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Valproic acid (VPA) in patients with refractory advanced cancer: a dose escalating phase I clinical trial.

Atmaca A, Al-Batran SE, Maurer A, Neumann A, Heinzel T, Hentsch B, Schwarz SE, Hövelmann S, Göttlicher M, Knuth A, Jäger E.

Br J Cancer. 2007 Jul 16;97(2):177-82. Epub 2007 Jun 19.

2.

Role of predicted metalloprotease motif of Jab1/Csn5 in cleavage of Nedd8 from Cul1.

Cope GA, Suh GS, Aravind L, Schwarz SE, Zipursky SL, Koonin EV, Deshaies RJ.

Science. 2002 Oct 18;298(5593):608-11. Epub 2002 Aug 15.

3.

Activation of p53 by conjugation to the ubiquitin-like protein SUMO-1.

Gostissa M, Hengstermann A, Fogal V, Sandy P, Schwarz SE, Scheffner M, Del Sal G.

EMBO J. 1999 Nov 15;18(22):6462-71.

4.

The ubiquitin-protein ligase E6-associated protein (E6-AP) serves as its own substrate.

Nuber U, Schwarz SE, Scheffner M.

Eur J Biochem. 1998 Jun 15;254(3):643-9.

5.

Characterization of human hect domain family members and their interaction with UbcH5 and UbcH7.

Schwarz SE, Rosa JL, Scheffner M.

J Biol Chem. 1998 May 15;273(20):12148-54.

6.

The ubiquitin-like proteins SMT3 and SUMO-1 are conjugated by the UBC9 E2 enzyme.

Schwarz SE, Matuschewski K, Liakopoulos D, Scheffner M, Jentsch S.

Proc Natl Acad Sci U S A. 1998 Jan 20;95(2):560-4.

7.

Synchronous Detection vs Pulse Counting for Sensitive Photomultiplier Detection Systems.

Nakamura JK, Schwarz SE.

Appl Opt. 1968 Jun 1;7(6):1073-8. doi: 10.1364/AO.7.001073.

PMID:
20068742

Supplemental Content

Loading ...
Support Center